{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T07:53:41Z","timestamp":1771919621218,"version":"3.50.1"},"reference-count":7,"publisher":"BMJ","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Archives of Disease in Childhood"],"published-print":{"date-parts":[[1989,9,1]]},"DOI":"10.1136\/adc.64.9.1231","type":"journal-article","created":{"date-parts":[[2008,12,22]],"date-time":"2008-12-22T22:13:07Z","timestamp":1229983987000},"page":"1231-1234","source":"Crossref","is-referenced-by-count":24,"title":["Prognostic importance of myelosuppression during maintenance treatment of lymphoblastic leukaemia. Leukaemia in Childhood Working Party of the Medical Research Council."],"prefix":"10.1136","volume":"64","author":[{"given":"G","family":"Dolan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J S","family":"Lilleyman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S M","family":"Richards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","reference":[{"key":"ref_1","first-page":"189","article-title":"Preliminary Report to the Medical Research Council by the Leukaemia Committee and the Working Party on Leukaemia in Childhood. Treatment of acute lymphoblastic leukaemia. Comparison of immunotherapy (BCG), intermittent methotrexate and no therapy after a five-month intensive cytotoxic regimen (Concord trial)","volume":"iv:","year":"1971","unstructured":"Preliminary Report to the Medical Research Council by the Leukaemia Committee and the Working Party on Leukaemia in Childhood. Treatment of acute lymphoblastic leukaemia. Comparison of immunotherapy (BCG), intermittent methotrexate and no therapy after a five-month intensive cytotoxic regimen (Concord trial). Br Med J 1971;iv:189-94.","journal-title":"Br Med J"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1200\/JCO.1986.4.12.1758","article-title":"Report to the Council by the Working Party on Leukaemia in Childhood. Medical Research Council Leukaemia TrialUKALL V: an attempt to reduce the immunosuppressive effects of therapy in childhood acute lymphoblastic leukemia","volume":"4","year":"1986","unstructured":"Report to the Council by the Working Party on Leukaemia in Childhood. Medical Research Council Leukaemia TrialUKALL V: an attempt to reduce the immunosuppressive effects of therapy in childhood acute lymphoblastic leukemia. J Clin Oncol 1986;4:1758-64.","journal-title":"J Clin Oncol"},{"key":"ref_3","first-page":"408","article-title":"Report to the Council by the Working Party on Leukaemia in Childhood. Improvement in treatment for children with acute lymphoblastic leukaemia","volume":"i:","author":"Lancet","year":"1972","unstructured":"Report to the Council by the Working Party on Leukaemia in Childhood. Improvement in treatment for children with acute lymphoblastic leukaemia. The Medical Research Council UKALL Trials, 1972-84. Lancet 1986;i:408-10.","journal-title":"The Medical Research Council UKALL Trials"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/1097-0142(197102)27:2<247::AID-CNCR2820270202>3.0.CO;2-C","article-title":"Drug dosage and remission duration in childhood lymphocytic leukemia","volume":"27","author":"Pinkel, D.; Hernandez, K.; Borella, L.","year":"1971","unstructured":"Pinkel D, Hernandez K, Borella L, et al. Drug dosage and remission duration in childhood lymphocytic leukemia. Cancer 1971;27:247-56.","journal-title":"Cancer"},{"key":"ref_5","first-page":"478","article-title":"The effect of drug dosage on outcome and infectious complications in the treatment of childhood lymphocytic leukemia","volume":"22","author":"J, Van Eys; iT, Chen; D, Berry","year":"1981","unstructured":"Van Eys J, Chen iT, Berry D, et al. The effect of drug dosage on outcome and infectious complications in the treatment of childhood lymphocytic leukemia. Proceedings of the American Society for Clinical Oncology 1981;22:478.","journal-title":"Proceedings of the American Society for Clinical Oncology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3109\/08880018809037365","article-title":"White cell count during maintenance chemotherapy for standard-risk childhood acute lymphoblastic leukemia: relation to relapse rate","volume":"5","author":"Schmiegelow, K.; Pulczynska, M.K.; Siep, M.","year":"1988","unstructured":"Schmiegelow K, Pulczynska MK, Siep M. White cell count during maintenance chemotherapy for standard-risk childhood acute lymphoblastic leukemia: relation to relapse rate. Pediatric Hematology and Oncology 1988;5:259-67.","journal-title":"Pediatric Hematology and Oncology"},{"key":"ref_7","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(87)91873-3","article-title":"6-Mercaptopurine dosage","author":"Pinkel, D.","year":"1987","unstructured":"Pinkel D. 6-Mercaptopurine dosage. Lancet 1987;ii:1267.","journal-title":"Lancet"}],"container-title":["Archives of Disease in Childhood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/adc.64.9.1231","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T00:05:30Z","timestamp":1601078730000},"score":1,"resource":{"primary":{"URL":"https:\/\/adc.bmj.com\/lookup\/doi\/10.1136\/adc.64.9.1231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,9,1]]},"references-count":7,"journal-issue":{"issue":"9","published-print":{"date-parts":[[1989,9,1]]}},"URL":"https:\/\/doi.org\/10.1136\/adc.64.9.1231","relation":{},"ISSN":["0003-9888","1468-2044"],"issn-type":[{"value":"0003-9888","type":"print"},{"value":"1468-2044","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989,9,1]]}}}